The Role of DAB2IP in Androgen Receptor Activation during Prostate Cancer Progression The authors showed that DAB2IP, a novel tumor suppressor in prostate cancer (PCa), can inhibit androgen-receptor (AR)-mediated cell growth and gene activation in PCa cells via distinct mechanisms. DAB2IP inhibits the genomic pathway by preventing AR nuclear translocation or phosphorylation and suppresses the non-genomic pathway via its unique functional domain to inactivate c-Src. [Oncogene] Abstract Increased Chemo-Sensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133+ Stem/Progenitor Cells to Battle Prostate Cancer Prostate cancer (PCa) stem/progenitor cells are known to have higher chemo-resistance than non-stem/progenitor cells, but the underlying molecular mechanism remains unclear. The authors found the expression of TR4 is significantly higher in PCa CD133+ stem/progenitor cells compared to CD133– non-stem/progenitor cells. [J Biol Chem] Abstract | Full Article Identification of Drug Candidate against Prostate Cancer from the Aspect of Somatic Cell Reprograming Scientists used the EOS (Early transposon Oct4 and Sox2 enhancer) system to select human prostate cancer (PCA) cells expressing high levels of OCT4. The OCT4-expressing PCA cells selected using the EOS system showed increased tumorigenicity and high resistance to docetaxel, both in vitro and in vivo. [Cancer Sci] Abstract A Novel IgE Antibody Targeting the Prostate-Specific Antigen as a Potential Prostate Cancer Therapy Researchers explored the properties of a novel mouse/human chimeric anti-prostate-specific antigen IgE containing the variable regions of AR47.47 as a potential therapy for prostate cancer (PCa). Their goal was to take advantage of the unique properties of IgE in order to trigger immune activation against PCa. [BMC Cancer] Abstract | Full Article MicroRNA-205, a Novel Regulator of the Anti-Apoptotic Protein Bcl2, Is Downregulated in Prostate Cancer Scientists determined the expression of microRNA (miR)-205 in 111 archival samples of prostate carcinoma and found it to be strongly reduced in most samples, with a median expression level of 16% in comparison to benign tissue from the same patient. Lower miR-205 expression correlated significantly with tumor size and miR-205 levels decreased with increasing Gleason score from 7a=3+4 to 8=4+4. [Int J Oncol] Abstract Anti-Oxidative and Anti-Proliferative Activity on Human Prostate Cancer Cells Lines of the Phenolic Compounds from Corylopsis coreana Uyeki Fifteen phenolic compounds, including three caffeoyl derivatives, four gallotannins, three ellagitannins and five flavonoids, were isolated from an 80% MeOH extract of the leaves of Corylopsis coreana Uyeki. The anti-oxidative activities and the anti-proliferative activity on human prostate cancer cell lines were evaluated. [Molecules] Abstract | Full Article Androgens and Estrogens Stimulate Ribosome Biogenesis in Prostate and Breast Cancer Cells in Receptor Dependent Manner Researchers investigated the link between estrogen and androgen receptor signaling and the initial stage of ribosome biogenesis – transcription of rRNA genes. They discovered that estrogen or androgen treatment can positively regulate rRNA synthesis in breast and prostate cancer cells respectively and that this effect is receptor dependent. [Gene] Abstract CLINICAL RESEARCH Genetic Markers Associated with Early Cancer-Specific Mortality following Prostatectomy Researchers sought to identify novel effectors and markers of localized but potentially life-threatening prostate cancer, by evaluating chromosomal copy number alterations in tumors from patients who underwent prostatectomy and correlating these with clinicopathologic features and outcome. Abstract | Press Release The Prostate Cancer-Up-Regulated myc-Associated Zinc-Finger Protein (MAZ) Modulates Proliferation and Metastasis through Reciprocal Regulation of Androgen Receptor The role of MAZ in prostate cancer (PCa) tumorigenesis and its interaction with androgen receptor (AR), which is essential to PCa development in humans, were investigated. MAZ expression was found to be higher in clinical PCa specimens than in benign prostatic hyperplasia and adjacent normal tissues, and MAZ expression was positively correlated with AR expression, which was also observed in PCa cell lines. [Med Oncol] Abstract Reduction of Prostate Cancer Incidence by Naftopidil, an α1-Adrenoceptor Antagonist and Transforming Growth Factor-β Signaling Inhibitor Quinazoline-based α1-adrenoceptor antagonists are known to inhibit prostate tumor growth through induction of apoptosis. Researchers investigated the effect of a naphthalene-based α1-adrenoceptor antagonist, naftopidil, on prostate cancer incidence, apoptosis of prostatic cell and transforming growth factor-β signaling. [Int J Urol] Abstract |